References
- Venge P. Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma. Clin Exp Allergy 1993; 23: 3, Suppl 2
- Robinson D S. Eosinophil and asthma. What do measurements tell us. Clin Exp Allergy 1995; 25: 795
- National Heart, Lung, and Blood Institute, National Institutes of Health. Establish medication plans for long-term management. Global Initiative for Asthma; Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. NIH Publication No. 95–3659. National Institutes of Health, Bethesda, MD 1995; 77–102
- Sugai T, Sakiyama Y, Matsumoto S. Eosinophil cat-ionic protein in peripheral blood of paediatric patients with allergic diseases. Clin Exp Allergy 1992; 22: 275
- Zimmerman B, Lanner A, Enander I, Zimmerman R S, Peterson C G, Ahlstedt S. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993; 23: 564
- Venge P, Dahl R, Karlstrom B, Pedersen B, Peterson C GB. Eosinophil activity in asthma in a one-year double-blind trial with theophylline and two doses of inhaled budesonide (abstract). J Allergy Clin Immunol 1992; 89: 190
- Baba K, Koishikawa T, Kobayashi T, Takgagi K, Ueno K. Long-term monitoring of serum eosinophil cationic protein and myeloperoxidase in asthmatic patients. Am J Respir Crit Care Med 1996; 153: A212
- Venge P, Dahl R, Peterson C GB. Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication. Int Arch Allergy Appl Immunol 1988; 87: 306
- Vatrella A, Ponticiello A, Parrella R, Romano L, Zofra S, Di Leva A, Bariffi F. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma. Allergy 1996; 51: 547
- Carlson M, Hakansson L, Kampe M, Stalenheim G, Peterson C, Venge P. Degranulation of eosinophils from pollen atopic patients with asthma is increased during pollen season. J Allergy Clin Immunol 1992; 89: 131
- Tsukioka K. Peak Expiratory Flow in Normal, Healthy Japanese Subjects. Kyowa-Kikaku, Tokyo 1995; 15–42
- Motojima S, Ogata H, Tateishi K, Fukuda T, Makino S, Koseki T, Adachi T, Kihara N. Measurement of serum and sputum eosinophil cationic protein concentrations in asthma (abstract in English). Jpn J Allergol 1995; 44: 1272
- Peterson C GB, Enander I, Nystrand J, Anderson A S, Nilsson L, Venge P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal level in serum and turnover in vivo. Clin Exp Allergy 1991; 21: 561
- De Backer W, Overveld F V, Vermeire P. Eosinophil products (ECP) as tools for safe tapering down of corticosteroid therapy in asthma. Am J Respir Crit Care Med 1996; 153: A336
- Wever A M, Wever-Hess J, Hensgens H ESJ, Hermans J. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20 and exacerbations. Respir Med 1994; 88: 613
- Venge P, Dahl R. Are blood eosinophil number and activity important for the development of the late asthmatic reaction after allergen challenge. Eur Respir J 1989; 2: 430s, Suppl 6
- Woolley K L, Adelroth E, Wooley M J, Ellis R, Jordana M, O'Byrne P M. Granulocyte macrophage colony-stimulating factor, eosinophil and eosinophil cationic protein in subjects with and without mild, stable atopic asthma. Eur Respir J 1994; 7: 1576
- Adachi T, Motojima S, Hirata A, Fukuda T, Makino S. Eosinophil viability-enhancing activity in sputum from patients with bronchial asthma, Contributions of interleukin-5 and granulocyte/macrophage colony-stimulating factor. Am J Respir Crit Care Med 1995; 151: 618